Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study (Q40355993)
Jump to navigation
Jump to search
scientific article published on 20 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study |
scientific article published on 20 June 2010 |
Statements
1 reference
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study (English)
1 reference
Benjamin Gesundheit
1 reference
Shimon Slavin
1 reference
Aliza Ackerstein
1 reference
Reuven Or
1 reference
Michael Y Shapira
1 reference
Nadir Askenasy
1 reference
Shoshana Morecki
1 reference
20 June 2010
1 reference
1 reference
1511-1519
1 reference
Identifiers
1 reference